Trial Profile
Double-blind placebo-controlled comparative study for the efficacy of treatment on the patient with NERD [gastro oesophageal reflux] between omeprasole versus omeprasole plus mosapride citrate
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Mar 2011
Price :
$35
*
At a glance
- Drugs Mosapride (Primary) ; Omeprazole
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- 13 Nov 2009 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 04 Jun 2009 Results have been presented at Digestive Disease Week 2009.
- 14 Jan 2008 The expected completion date for this trial is now 1 Dec 2008.